Real-World Data in Support of Short Sleep Duration with Poor Glycemic Control, in People with Type 2 Diabetes Mellitus

Table 2

Prevalence ratios for short and long sleep durations, compared to intermediate sleep duration. Variables with in the univariate log-binomial analysis.

Variables	Model S: short sleep duration	Model L: long sleep duration
	PR (95% CI)	PR (95% CI)
Female gender	1.53 (0.83–2.81)	1.50 (0.49–4.59)
Education (years)	0.95 (0.89–1.02)	0.86 (0.76-0.98)
Time since T2DM diagnosis (years)	1.06 (1.01–1.10)	1.12 (1.02–1.22)
Number of insulin users	1.33 (0.70–2.53)	4.40 (1.39–13.99)
Number of patients that used per week	1.75 (0.96–3.20)	2.43 (0.80–7.44)
HbA1c (%)	1.28 (1.13–1.44)	1.25 (0.94–1.66)
Caffeine intake (mg/day)	1.001 (0.999–1.002)	1.001 (1.001–1.003)
STOP-BANG Questionnaire score	1.11 (0.96–1.29)	1.31 (1.03-1.68)
Number of patients with STOP-BANG Questionnaire	1.51 (0.78–2.95)	7.03 (0.93-53)
Chronotype (MEQ score)	1.01 (0.98–1.03)	1.04 (0.99–1.10)
Cognitive restriction (%)	0.987 (0.97–1.00)	0.98 (0.96–1.02)
Emotional eating (%)	1.01 (0.99–1.020)	0.98 (0.96–1.0)
PHQ-9 score	1.06 (1.02–1.10)	0.96 (0.85–1.07)
Nocturia days per week	0.98 (0.75–1.29)	3.47 (1.28–9.42)
Number of patients with night pain days per	1.80 (0.96–3.36)	1.77 (0.57-5.45)
Modified Pittsburgh Sleep Quality Index	1.03 (0.94–1.13)	0.80 (0.67–0.95)

PR: prevalence ratio; 95% CI: 95% confidence interval; T2DM: type 2 diabetes mellitus; HbA_1c: glycohemoglobin; MEQ: Morningness-Eveningness Questionnaire; PHQ-9: Patient Health Questionnaire; ; .